Lakefront Biotherapeutics (GLPGF) Change in Taxes (2015 - 2022)

Lakefront Biotherapeutics (GLPGF) has reported Change in Taxes for 8 consecutive years, with -$4.5 million the latest figure, recorded in Q4 2022.

• On a quarterly basis, Change in Taxes fell 478.01% year-over-year to -$4.5 million in Q4 2022; TTM through Dec 2022 was -$7.0 million, a 182.45% decrease from a year earlier, with the FY2025 full-year figure at -$420289.8, down 195.64% from the prior year.
• Change in Taxes was -$4.5 million for Q4 2022 at Lakefront Biotherapeutics, down from -$782476.1 in the prior quarter.
• Over five years, Change in Taxes peaked at -$9131.2 in Q4 2018 and troughed at -$4.5 million in Q4 2022.
• A 5-year average of -$1.4 million and a median of -$782476.1 in 2021 frame the typical range for Change in Taxes.
• Across the five-year window, Change in Taxes soared 96.1% in 2018 and slumped 2466.28% in 2020, its largest moves.
• Over 5 years, Change in Taxes stood at -$9131.2 in 2018, then plunged by 590.96% to -$63092.6 in 2019, then sank by 2466.28% to -$1.6 million in 2020, then jumped by 51.67% to -$782476.1 in 2021, then sank by 478.01% to -$4.5 million in 2022.
• The last three Change in Taxes figures came in at -$4.5 million (Q4 2022), -$782476.1 (Q4 2021), and -$1.6 million (Q4 2020), per Business Quant data.